| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.055 | 0.8 |